Plaio Secures €4.3M Funding to Enhance AI Pharma Planning Solutions
Plaio is revolutionizing pharmaceutical supply chain planning with AI-driven solutions, combining deep industry knowledge with innovative technology to deliver substantial operational advantages to pharma companies worldwide.
Company Name: Plaio
Location: Reykjavik, Iceland
Sector: Pharmaceutical, AI Technology
Funding Details: Raised €4.3 million in a funding round led by Iðunn, with participation from existing investors Frumtak Ventures and Dr. Agon.
Purpose of Investment: To implement strategic enhancements to the platform’s “AI Coplanner” and strengthen partnerships within the pharmaceutical industry.
Leadership: Founded by Johann Gudbjargarson, Hlynur Stefansson, and Eyjolfur Ingi Asgeirsson, Plaio is pioneering AI-driven solutions to optimize the pharmaceutical supply chain planning.
Product and Innovation: Plaio’s AI-assisted decision support platform integrates industry expertise with advanced AI technology to streamline complex planning processes, enhancing operational efficiency in the pharmaceutical sector. The "AI Coplanner" feature is designed to further improve planning accuracy and efficiency.
Company Growth: Plaio has seen a 200% increase in its client portfolio over the last 12 months. Notable clients include Covis Pharma, Alvotech, and Camarus, which reflect the platform’s expanding influence and application across global pharmaceutical operations.
About the Company: Plaio is revolutionizing pharmaceutical supply chain planning with AI-driven solutions, combining deep industry knowledge with innovative technology to deliver substantial operational advantages to pharma companies worldwide.
